
You can purchase shares of PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. (OTCPK:PBIGF) through any online brokerage.
There are no as such competitors for PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd..
There is no analysis for PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. to provide a consensus price target.
The stock price for PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. (OTCPK: PBIGF) is $0.0119 last updated October 22, 2026 at 12:27 PM EDT.
There are no upcoming dividends for PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd..
PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. does not have any upcoming earnings scheduled.
There is no upcoming split for PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd..
PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia. The firm is engaged in developing injectable pentosan polysulfate sodium (iPPS)...